Project Grant R21AI185488
Award Date 7/25/24
Completion Date 6/30/27
Dollars Obligated $621K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Columbia, MO 65211, USA
Similar Awards
- Federal Grant Award Summary Applied Biomedical Science Institute received a $976,318 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective April 6, 2026, with a completion date of March 31, 2031. The research focuses on elucidating the molecular mechanisms underlying bovine antibody structural variegation, specifically the generation of ultralong complementarity-determining...
- Federal Grant Award Summary The University of Massachusetts Medical School received a $460,625 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 9, 2026, with a completion date of January 31, 2028. The research project, "Eliciting TH1/TH17 Dual Responses for Vaccine-Induced Immunity to Tuberculosis," investigates mechanisms by which the Bacillus...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $204,375 to the Trustees of Boston University (Boston University Medical Campus) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop next-generation human immune system (HIS) mice models for vaccine testing against high-containment viruses. The project, which commenced June 1, 2026 and concludes May 31, 2028, addresses a critical gap in vaccine development...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $815,378 Project Grant to the Trustees of Boston University (Boston University Medical Campus) effective May 1, 2026, through April 30, 2031, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The research initiative focuses on identifying and characterizing high-affinity germline-encoded antibodies that can neutralize viral pathogens causing significant...
- Federal Project Grant Award Summary Award Details: Abvacc, Inc. received a $638,953 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award was issued on August 22, 2025, with a completion date of July 31, 2030, and performance will be conducted in Rockville, Maryland. Products and Services: The grant funds development of an immunotherapeutic antibody cocktail for treating...
- Federal Grant Award Summary Albany Medical College received a $164,000 Project Grant award from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective June 6, 2025, with completion targeted for May 31, 2027. The project, "Development of Conformer-Specific Anti-I-A Class II Monoclonal Antibodies," focuses on identifying and characterizing novel monoclonal antibodies (MAbs) that selectively recognize...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Massachusetts General Hospital a Project Grant of $439,088 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective July 8, 2025, through July 7, 2027. The award supports research led by Dr. Daniel Lingwood, Associate Professor of Medicine at the Ragon Institute of Mass General, MIT and Harvard, to mechanistically define how sex differences in hormones and...
- Grant Award Summary Boston University Medical Campus received a $245,250 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on February 9, 2026, with a completion date of January 31, 2028. This research initiative investigates the mechanisms of alternative macrophage activation in pulmonary tuberculosis (TB), focusing on understanding the phenotypes and genesis of arginase 1...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Texas Biomedical Research Institute $905,998 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to evaluate the safety, immunogenicity, and efficacy of a novel attenuated Mycobacterium tuberculosis (MTB) vaccine candidate in the context of HIV co-infection. Commencing June 17, 2025, and extending through May 31, 2030, this project will leverage the institute's...
- Federal Project Grant Award Summary Albert Einstein College of Medicine received a $780,787 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective January 27, 2026, with completion targeted for December 31, 2030. The award supports fundamental research aimed at understanding how T cell receptor (TCR) recognition of peptide ligands shapes memory CD8+ T cell programming, with...